SIRION Biotech Licenses Technology to National Institute of Allergy and Infectious Diseases to Boost Clinical Efficacy of Lentivector Gene Therapy for X-Linked SCID
MARTINSRIED, Germany--(BUSINESS WIRE)--Jun 11, 2019--
MARTINSRIED, Germany--(BUSINESS WIRE)--Jun 11, 2019--